Metabolic complications in liver transplant recipients (Q28073134)

Rocío González-Grande

2

1 reference

Edith Omonte Guzmán

3

1 reference

Víctor Amo Trillo

4

1 reference

Juan Miguel Rodrigo López

5

1 reference

language of work or name

1 reference

28 July 2016

1 reference

World Journal of Gastroenterology

published in

1 reference

volume

22

1 reference

page(s)

6416-23

1 reference

issue

28

1 reference

Metabolic and cardiovascular complications in the liver transplant recipient

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968123

Calcineurin inhibition and new-onset diabetes mellitus after transplantation

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968123

Hepatitis C virus hijacks host lipid metabolism

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968123

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968123

Diabetes risk gene and Wnt effector Tcf7l2/TCF4 controls hepatic response to perinatal and adult metabolic demand

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968123

Metabolic syndrome after liver transplantation: preventable illness or common consequence?

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968123

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968123

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968123

The Origin of New-Onset Diabetes After Liver Transplantation: Liver, Islets, or Gut?

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968123

Risk of de novo post-transplant type 2 diabetes in patients undergoing liver transplant for non-alcoholic steatohepatitis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968123

Risk factors of metabolic syndrome after liver transplantation.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968123

Donor PPARα Gene Polymorphisms Influence the Susceptibility to Glucose and Lipid Disorders in Liver Transplant Recipients: A Strobe-Compliant Observational Study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968123

Contribution of β-cell dysfunction and insulin resistance to cirrhosis-associated diabetes: Role of severity of liver disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968123

Risk factors of metabolic disorders after liver transplantation: an analysis of data from fasted patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968123

Liver transplantation for nonalcoholic fatty liver disease: new challenges and new opportunities

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968123

The Role of mTOR Inhibitors in Liver Transplantation: Reviewing the Evidence

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968123

New Onset Diabetes Mellitus in Living Donor versus Deceased Donor Liver Transplant Recipients: Analysis of the UNOS/OPTN Database

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968123

Is liver transplantation a risk factor for cardiovascular disease? A meta-analysis of observational studies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968123

Cardiovascular consequences of new-onset hyperglycemia after kidney transplantation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968123

Complications associated with liver transplantation in the obese recipient

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968123

Unique cellular and mitochondrial defects mediate FK506-induced islet β-cell dysfunction.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968123

Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968123

Metabolic syndrome and liver transplantation: a review and guide to management

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968123

Posttransplant metabolic syndrome: an epidemic waiting to happen

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968123

Liver transplantation at the extremes of the body mass index

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968123

New onset diabetes mellitus after liver transplantation and hepatitis C virus infection: meta-analysis of clinical studies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968123

Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968123

Impact of diabetes on the severity of liver disease.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968123

Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968123

Cardiovascular morbidity and mortality after orthotopic liver transplantation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968123

Tacrolimus conversion improves hyperlipidemic states in stable liver transplant recipients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968123

New-onset diabetes after liver transplantation and its impact on complications and patient survival

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968123

Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968123

Risk of development of the metabolic syndrome after orthotopic liver transplantation

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968123

Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968123

Late hypertension after liver transplantation: a comparison of cyclosporine and tacrolimus (FK 506).

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968123

Weight change and obesity after liver transplantation: incidence and risk factors.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968123

Systemic and renal effects of nifedipine in cyclosporine-associated hypertension.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968123

Liver transplantation for acute liver failure in Europe: outcomes over 20 years from the ELTR database

2 June 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I28.6416

Metabolic syndrome in liver transplantation: relation to etiology and immunosuppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I28.6416

Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I28.6416

Metabolic syndrome after liver transplantation: prevalence and predictive factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I28.6416

Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I28.6416

Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I28.6416

Weight gain and obesity after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I28.6416

Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I28.6416

Control of blood pressure in liver transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I28.6416

Diabetes, hypertension and hyperlipidemia: prevalence over time and impact on long-term survival after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I28.6416

Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months1

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I28.6416

Is there disparity between risk and incidence of cardiovascular disease after liver transplant?

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I28.6416

Incidence and risk factors for new-onset diabetes in living-donor liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I28.6416

Association between donor and recipient TCF7L2 gene polymorphisms and the risk of new-onset diabetes mellitus after liver transplantation in a Han Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I28.6416

Major influence of liver function itself but not of immunosuppression determines glucose tolerance after living-donor liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I28.6416

Influence of CYP3A5 gene polymorphisms of donor rather than recipient to tacrolimus individual dose requirement in liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I28.6416

Relationship between hepatitis C virus recurrence and de novo diabetes after liver transplantation: the Hungarian experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I28.6416

Impact of preexisting diabetes mellitus on outcome after liver transplantation in patients with hepatitis B virus-related liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I28.6416

mTOR inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I28.6416

Cardiovascular risk factors after liver transplantation: analysis of related factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I28.6416

Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I28.6416

Prednisone withdrawal late after adult liver transplantation reduces diabetes, hypertension, and hypercholesterolemia without causing graft loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I28.6416

Corticosteroid-free immunosuppression with tacrolimus following induction with daclizumab: a large randomized clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I28.6416

Immunosuppression impact on long-term cardiovascular complications after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I28.6416

Tacrolimus as intervention in the treatment of hyperlipidemia after liver transplant.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I28.6416

Dyslipidemia during sirolimus therapy in liver transplant recipients occurs with concomitant cyclosporine but not tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I28.6416

Sirolimus changes lipid concentrations and lipoprotein metabolism in kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I28.6416

Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I28.6416

Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I28.6416

Analysis of causes of death in liver transplant recipients who survived more than 3 years

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I28.6416

Insulin resistance, serum adipokines and risk of fibrosis progression in patients transplanted for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I28.6416

De novo nonalcoholic fatty liver disease after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I28.6416

Alternative human liver transcripts of TCF7L2 bind to the gluconeogenesis regulator HNF4α at the protein level

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V22.I28.6416

Cumulative risk of cardiovascular events after orthotopic liver transplantation.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968123

Post-transplant diabetes mellitus in liver transplantation: Hangzhou experience

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4968123

Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: effect of liver transplantation

27 November 2018

1 reference

12 December 2020

Recurrence of non-alcoholic steatohepatitis and cryptogenic cirrhosis following orthotopic liver transplantation in the context of the metabolic syndrome

1 reference

12 December 2020

[Impact of immunossuppression in the cardiovascular risk profile after renal transplantation I]

1 reference

12 December 2020

Changes in quality of life after liver transplantation among adults. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Liver Transplantation Database (LTD)

1 reference

12 December 2020

The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation

1 reference

12 December 2020

Abstracts of the 59th Annual Meeting of the American Association for the Study of Liver Diseases, 2008. October 31-November 4, 2008. San Francisco, California, USA

1 reference

12 December 2020

Prevalence and clinical associations of posttransplant fatty liver disease

1 reference

12 December 2020

The impact of obesity on long-term outcomes in liver transplant recipients-results of the NIDDK liver transplant database

1 reference

12 December 2020

1 reference

12 December 2020

Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation

1 reference

12 December 2020

The long-term survival and causes of death in patients who survive at least 1 year after liver transplantation

1 reference

12 December 2020

NAFLD recurrence in liver transplant recipients

1 reference

12 December 2020